Report Detail

Medical Industry Global Preeclampsia Laboratory Testing Market Growth (Status and Outlook) 2022-2028

  • RnM4398778
  • |
  • 15 March, 2022
  • |
  • Global
  • |
  • 102 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

As the global economy mends, the 2021 growth of Preeclampsia Laboratory Testing will have significant change from previous year. According to our (LP Information) latest study, the global Preeclampsia Laboratory Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Preeclampsia Laboratory Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Preeclampsia Laboratory Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Preeclampsia Laboratory Testing market, reaching US$ million by the year 2028. As for the Europe Preeclampsia Laboratory Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Preeclampsia Laboratory Testing players cover PerkinElmer Inc., F. Hoffmann-La Roche Ltd., ThermoFischer Scientific Inc., and SERA Prognostics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Preeclampsia Laboratory Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Blood Tests
Urine Tests

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals and Clinics
Diagnostics Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

PerkinElmer Inc.
F. Hoffmann-La Roche Ltd.
ThermoFischer Scientific Inc.
SERA Prognostics
Bayer AG,
Siemens Healthineers AG
Metabolomic Diagnostics Ltd.
DiabetOmics Inc.,
DRG INSTRUMENTS GMBH
Progenity Inc.


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Preeclampsia Laboratory Testing Market Size 2017-2028
    • 2.1.2 Preeclampsia Laboratory Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Preeclampsia Laboratory Testing Segment by Type
    • 2.2.1 Blood Tests
    • 2.2.2 Urine Tests
  • 2.3 Preeclampsia Laboratory Testing Market Size by Type
    • 2.3.1 Preeclampsia Laboratory Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Preeclampsia Laboratory Testing Market Size Market Share by Type (2017-2022)
  • 2.4 Preeclampsia Laboratory Testing Segment by Application
    • 2.4.1 Hospitals and Clinics
    • 2.4.2 Diagnostics Centers
    • 2.4.3 Others
  • 2.5 Preeclampsia Laboratory Testing Market Size by Application
    • 2.5.1 Preeclampsia Laboratory Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Preeclampsia Laboratory Testing Market Size Market Share by Application (2017-2022)

3 Preeclampsia Laboratory Testing Market Size by Player

  • 3.1 Preeclampsia Laboratory Testing Market Size Market Share by Players
    • 3.1.1 Global Preeclampsia Laboratory Testing Revenue by Players (2020-2022)
    • 3.1.2 Global Preeclampsia Laboratory Testing Revenue Market Share by Players (2020-2022)
  • 3.2 Global Preeclampsia Laboratory Testing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Preeclampsia Laboratory Testing by Regions

  • 4.1 Preeclampsia Laboratory Testing Market Size by Regions (2017-2022)
  • 4.2 Americas Preeclampsia Laboratory Testing Market Size Growth (2017-2022)
  • 4.3 APAC Preeclampsia Laboratory Testing Market Size Growth (2017-2022)
  • 4.4 Europe Preeclampsia Laboratory Testing Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Preeclampsia Laboratory Testing Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Preeclampsia Laboratory Testing Market Size by Country (2017-2022)
  • 5.2 Americas Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
  • 5.3 Americas Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Preeclampsia Laboratory Testing Market Size by Region (2017-2022)
  • 6.2 APAC Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
  • 6.3 APAC Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Preeclampsia Laboratory Testing by Country (2017-2022)
  • 7.2 Europe Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
  • 7.3 Europe Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Preeclampsia Laboratory Testing by Region (2017-2022)
  • 8.2 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Preeclampsia Laboratory Testing Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Preeclampsia Laboratory Testing Market Forecast

  • 10.1 Global Preeclampsia Laboratory Testing Forecast by Regions (2023-2028)
    • 10.1.1 Global Preeclampsia Laboratory Testing Forecast by Regions (2023-2028)
    • 10.1.2 Americas Preeclampsia Laboratory Testing Forecast
    • 10.1.3 APAC Preeclampsia Laboratory Testing Forecast
    • 10.1.4 Europe Preeclampsia Laboratory Testing Forecast
    • 10.1.5 Middle East & Africa Preeclampsia Laboratory Testing Forecast
  • 10.2 Americas Preeclampsia Laboratory Testing Forecast by Country (2023-2028)
    • 10.2.1 United States Preeclampsia Laboratory Testing Market Forecast
    • 10.2.2 Canada Preeclampsia Laboratory Testing Market Forecast
    • 10.2.3 Mexico Preeclampsia Laboratory Testing Market Forecast
    • 10.2.4 Brazil Preeclampsia Laboratory Testing Market Forecast
  • 10.3 APAC Preeclampsia Laboratory Testing Forecast by Region (2023-2028)
    • 10.3.1 China Preeclampsia Laboratory Testing Market Forecast
    • 10.3.2 Japan Preeclampsia Laboratory Testing Market Forecast
    • 10.3.3 Korea Preeclampsia Laboratory Testing Market Forecast
    • 10.3.4 Southeast Asia Preeclampsia Laboratory Testing Market Forecast
    • 10.3.5 India Preeclampsia Laboratory Testing Market Forecast
    • 10.3.6 Australia Preeclampsia Laboratory Testing Market Forecast
  • 10.4 Europe Preeclampsia Laboratory Testing Forecast by Country (2023-2028)
    • 10.4.1 Germany Preeclampsia Laboratory Testing Market Forecast
    • 10.4.2 France Preeclampsia Laboratory Testing Market Forecast
    • 10.4.3 UK Preeclampsia Laboratory Testing Market Forecast
    • 10.4.4 Italy Preeclampsia Laboratory Testing Market Forecast
    • 10.4.5 Russia Preeclampsia Laboratory Testing Market Forecast
  • 10.5 Middle East & Africa Preeclampsia Laboratory Testing Forecast by Region (2023-2028)
    • 10.5.1 Egypt Preeclampsia Laboratory Testing Market Forecast
    • 10.5.2 South Africa Preeclampsia Laboratory Testing Market Forecast
    • 10.5.3 Israel Preeclampsia Laboratory Testing Market Forecast
    • 10.5.4 Turkey Preeclampsia Laboratory Testing Market Forecast
    • 10.5.5 GCC Countries Preeclampsia Laboratory Testing Market Forecast
  • 10.6 Global Preeclampsia Laboratory Testing Forecast by Type (2023-2028)
  • 10.7 Global Preeclampsia Laboratory Testing Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 PerkinElmer Inc.
    • 11.1.1 PerkinElmer Inc. Company Information
    • 11.1.2 PerkinElmer Inc. Preeclampsia Laboratory Testing Product Offered
    • 11.1.3 PerkinElmer Inc. Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 PerkinElmer Inc. Main Business Overview
    • 11.1.5 PerkinElmer Inc. Latest Developments
  • 11.2 F. Hoffmann-La Roche Ltd.
    • 11.2.1 F. Hoffmann-La Roche Ltd. Company Information
    • 11.2.2 F. Hoffmann-La Roche Ltd. Preeclampsia Laboratory Testing Product Offered
    • 11.2.3 F. Hoffmann-La Roche Ltd. Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
    • 11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
  • 11.3 ThermoFischer Scientific Inc.
    • 11.3.1 ThermoFischer Scientific Inc. Company Information
    • 11.3.2 ThermoFischer Scientific Inc. Preeclampsia Laboratory Testing Product Offered
    • 11.3.3 ThermoFischer Scientific Inc. Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 ThermoFischer Scientific Inc. Main Business Overview
    • 11.3.5 ThermoFischer Scientific Inc. Latest Developments
  • 11.4 SERA Prognostics
    • 11.4.1 SERA Prognostics Company Information
    • 11.4.2 SERA Prognostics Preeclampsia Laboratory Testing Product Offered
    • 11.4.3 SERA Prognostics Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 SERA Prognostics Main Business Overview
    • 11.4.5 SERA Prognostics Latest Developments
  • 11.5 Bayer AG,
    • 11.5.1 Bayer AG, Company Information
    • 11.5.2 Bayer AG, Preeclampsia Laboratory Testing Product Offered
    • 11.5.3 Bayer AG, Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Bayer AG, Main Business Overview
    • 11.5.5 Bayer AG, Latest Developments
  • 11.6 Siemens Healthineers AG
    • 11.6.1 Siemens Healthineers AG Company Information
    • 11.6.2 Siemens Healthineers AG Preeclampsia Laboratory Testing Product Offered
    • 11.6.3 Siemens Healthineers AG Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Siemens Healthineers AG Main Business Overview
    • 11.6.5 Siemens Healthineers AG Latest Developments
  • 11.7 Metabolomic Diagnostics Ltd.
    • 11.7.1 Metabolomic Diagnostics Ltd. Company Information
    • 11.7.2 Metabolomic Diagnostics Ltd. Preeclampsia Laboratory Testing Product Offered
    • 11.7.3 Metabolomic Diagnostics Ltd. Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Metabolomic Diagnostics Ltd. Main Business Overview
    • 11.7.5 Metabolomic Diagnostics Ltd. Latest Developments
  • 11.8 DiabetOmics Inc.,
    • 11.8.1 DiabetOmics Inc., Company Information
    • 11.8.2 DiabetOmics Inc., Preeclampsia Laboratory Testing Product Offered
    • 11.8.3 DiabetOmics Inc., Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 DiabetOmics Inc., Main Business Overview
    • 11.8.5 DiabetOmics Inc., Latest Developments
  • 11.9 DRG INSTRUMENTS GMBH
    • 11.9.1 DRG INSTRUMENTS GMBH Company Information
    • 11.9.2 DRG INSTRUMENTS GMBH Preeclampsia Laboratory Testing Product Offered
    • 11.9.3 DRG INSTRUMENTS GMBH Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 DRG INSTRUMENTS GMBH Main Business Overview
    • 11.9.5 DRG INSTRUMENTS GMBH Latest Developments
  • 11.10 Progenity Inc.
    • 11.10.1 Progenity Inc. Company Information
    • 11.10.2 Progenity Inc. Preeclampsia Laboratory Testing Product Offered
    • 11.10.3 Progenity Inc. Preeclampsia Laboratory Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Progenity Inc. Main Business Overview
    • 11.10.5 Progenity Inc. Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Preeclampsia Laboratory Testing. Industry analysis & Market Report on Preeclampsia Laboratory Testing is a syndicated market report, published as Global Preeclampsia Laboratory Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Preeclampsia Laboratory Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,924.34
5,848.68
3,414.78
6,829.56
569,313.00
1,138,626.00
304,987.80
609,975.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report